Off-pump left ventricle reconstruction using the Revivent Myocardial Anchoring System in patients with severe ischemic cardiomyopathy.
- Conditions
- 1001928010007593Ischaemic cardiomyopathyischaemic heart failure
- Registration Number
- NL-OMON44507
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 10
The following criteria will be applied for inclusion:;- > 18 years of age
- Able to provide written informed consent
- Medical history of antero-septal myocardial infarction with a discreet akinetic/dyskinetic scar located in the antero-septal or apical (may extend laterally) regions of the LV
- Dilated left ventricle with or without aneurysm
- Left ventricular end-systolic volume index (LVESVI) * 60ml/m2
- Left ventricular ejection fraction (LVEF) * 40%
- Symptomatic cardiac dysfunction causing heart failure: NYHA class * II
- Maintenance on stable medical therapy in accordance with prevailing heart failureguidelines
- Mitral valve regurgitation * 1
- With or without cardiac device (ICD/CRT)
Patients are not eligible for the study if they meet the following criteria: ;- Unable or unwilling to provide written informed consent
- * 18 years of age
- Pregnancy or claustrophobia
- Known concomitant disease with a life expectancy of <1 year
- Calcified ventricular wall in the area of intended scar exclusion
- Thrombus or mass in the left atrium or ventricle
- CRT device placement * 60 days prior to surgery
- Thin walled, paradoxically moving septal scar that would preclude successful support of the anchor pairs
- Significant diastolic dysfunction, defined as a pseudo-normal Doppler filling pattern with E/A ratio>2
- Intolerance or unwillingness to take Acenocoumarol
- Functioning pacemaker leads in antero-apical RV, which would interfere with anchor placement
- Pulmonary arterial pressure > 60 mm Hg
- Myocardial infarction within 90 days prior to surgery
- Chronic renal failure with a serum creatinine > 250 µmol/l.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method